270 related articles for article (PubMed ID: 34924889)
1. Advances in the Management of Renal Dysfunction in Patients With Cirrhosis.
Pena Polanco NA; Martin P; Carrion AF
Gastroenterol Hepatol (N Y); 2021 May; 17(5):211-220. PubMed ID: 34924889
[TBL] [Abstract][Full Text] [Related]
2. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.
Boyer TD; Sanyal AJ; Wong F; Frederick RT; Lake JR; O'Leary JG; Ganger D; Jamil K; Pappas SC;
Gastroenterology; 2016 Jun; 150(7):1579-1589.e2. PubMed ID: 26896734
[TBL] [Abstract][Full Text] [Related]
3. New Developments in Hepatorenal Syndrome.
Mindikoglu AL; Pappas SC
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):162-177.e1. PubMed ID: 28602971
[TBL] [Abstract][Full Text] [Related]
4. Hepatorenal syndrome and novel advances in its management.
Fabrizi F; Aghemo A; Messa P
Kidney Blood Press Res; 2013; 37(6):588-601. PubMed ID: 24356549
[TBL] [Abstract][Full Text] [Related]
5. Results of pretransplant treatment of hepatorenal syndrome with terlipressin.
Solà E; Cárdenas A; Ginès P
Curr Opin Organ Transplant; 2013 Jun; 18(3):265-70. PubMed ID: 23652609
[TBL] [Abstract][Full Text] [Related]
6. News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document.
Angeli P; Garcia-Tsao G; Nadim MK; Parikh CR
J Hepatol; 2019 Oct; 71(4):811-822. PubMed ID: 31302175
[TBL] [Abstract][Full Text] [Related]
7. Management of hepatorenal syndrome.
Dundar HZ; Yılmazlar T
World J Nephrol; 2015 May; 4(2):277-86. PubMed ID: 25949942
[TBL] [Abstract][Full Text] [Related]
8. Terlipressin in hepatorenal syndrome: Evidence for present indications.
Rajekar H; Chawla Y
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
[TBL] [Abstract][Full Text] [Related]
9. Monitoring Renal Function and Therapy of Hepatorenal Syndrome Patients with Cirrhosis.
Juanola A; Solé C; Toapanta D; Ginès P; Solà E
Clin Liver Dis; 2021 May; 25(2):441-460. PubMed ID: 33838860
[TBL] [Abstract][Full Text] [Related]
10. Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectives.
Kulkarni AV; Arab JP; Premkumar M; Benítez C; Tirumalige Ravikumar S; Kumar P; Sharma M; Reddy DN; Simonetto DA; Rao PN
Liver Int; 2020 Dec; 40(12):2888-2905. PubMed ID: 33065772
[TBL] [Abstract][Full Text] [Related]
11. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
Arroyo V; Jiménez W
J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
[TBL] [Abstract][Full Text] [Related]
12. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
Martín-Llahí M; Pépin MN; Guevara M; Díaz F; Torre A; Monescillo A; Soriano G; Terra C; Fábrega E; Arroyo V; Rodés J; Ginès P;
Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
[TBL] [Abstract][Full Text] [Related]
13. A study on clinical outcomes of combination of terlipressin and albumin in Hepatorenal Syndrome.
Krishna R; Raj J; Dev D; Prasad SC; Reghu R; V SO
Scand J Gastroenterol; 2020 Jul; 55(7):860-864. PubMed ID: 32634332
[TBL] [Abstract][Full Text] [Related]
14. Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome.
Krag A; Møller S; Henriksen JH; Holstein-Rathlou NH; Larsen FS; Bendtsen F
Hepatology; 2007 Dec; 46(6):1863-71. PubMed ID: 18027874
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in our understanding of hepatorenal syndrome.
Wong F
Nat Rev Gastroenterol Hepatol; 2012 May; 9(7):382-91. PubMed ID: 22614754
[TBL] [Abstract][Full Text] [Related]
16. Hepatorenal Syndrome Type 1: Current Challenges And Future Prospects.
Facciorusso A
Ther Clin Risk Manag; 2019; 15():1383-1391. PubMed ID: 31819465
[TBL] [Abstract][Full Text] [Related]
17. Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome.
Wong F; Boyer TD; Sanyal AJ; Pappas SC; Escalante S; Jamil K
Nephrol Dial Transplant; 2020 Sep; 35(9):1554-1561. PubMed ID: 30887050
[TBL] [Abstract][Full Text] [Related]
18. Terlipressin for the treatment of hepatorenal syndrome: an overview of current evidence.
Zhang J; Rössle M; Zhou X; Deng J; Liu L; Qi X
Curr Med Res Opin; 2019 May; 35(5):859-868. PubMed ID: 30474439
[TBL] [Abstract][Full Text] [Related]
19. A new look at renal dysfunction in the cirrhotic patient.
Francoz C; Durand F
Crit Care; 2012 Dec; 16(2):118. PubMed ID: 22385933
[TBL] [Abstract][Full Text] [Related]
20. [Hepatorenal syndrome].
Mancini E
G Ital Nefrol; 2012; 29(5):563-78. PubMed ID: 23117737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
